- Home
- XERS vs ICHR Comparison
XERS vs ICHR Comparison
Compare XERS & ICHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- ICHR
- Stock Information
- Founded
- XERS 2005
- ICHR 1999
- Country
- XERS United States
- ICHR United States
- Employees
- XERS N/A
- ICHR N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- ICHR Semiconductors
- Sector
- XERS Health Care
- ICHR Technology
- Exchange
- XERS Nasdaq
- ICHR Nasdaq
- Market Cap
- XERS 752.7M
- ICHR 727.6M
- IPO Year
- XERS 2018
- ICHR 2016
- Fundamental
- Price
- XERS $5.11
- ICHR $23.77
- Analyst Decision
- XERS Strong Buy
- ICHR Strong Buy
- Analyst Count
- XERS 6
- ICHR 6
- Target Price
- XERS $6.25
- ICHR $33.60
- AVG Volume (30 Days)
- XERS 2.0M
- ICHR 405.0K
- Earning Date
- XERS 08-07-2025
- ICHR 08-04-2025
- Dividend Yield
- XERS N/A
- ICHR N/A
- EPS Growth
- XERS N/A
- ICHR N/A
- EPS
- XERS N/A
- ICHR N/A
- Revenue
- XERS $222,551,000.00
- ICHR $892,122,000.00
- Revenue This Year
- XERS $35.03
- ICHR $14.18
- Revenue Next Year
- XERS $18.31
- ICHR $6.66
- P/E Ratio
- XERS N/A
- ICHR N/A
- Revenue Growth
- XERS 29.88
- ICHR 13.41
- 52 Week Low
- XERS $2.10
- ICHR $15.33
- 52 Week High
- XERS $6.07
- ICHR $42.70
- Technical
- Relative Strength Index (RSI)
- XERS 61.48
- ICHR 72.93
- Support Level
- XERS $4.62
- ICHR $21.80
- Resistance Level
- XERS $5.39
- ICHR $24.12
- Average True Range (ATR)
- XERS 0.21
- ICHR 1.08
- MACD
- XERS 0.07
- ICHR 0.47
- Stochastic Oscillator
- XERS 71.72
- ICHR 95.06
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About ICHR Ichor Holdings
Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.